Holen Sie sich die Stockscreener-App
18.62
3.17%
-0.61
Handel nachbörslich:
18.62
Schlusskurs vom Vortag:
$19.23
Offen:
$19.13
24-Stunden-Volumen:
468.93K
Relative Volume:
1.86
Marktkapitalisierung:
$697.33M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+21.94%
1M Leistung:
+25.81%
6M Leistung:
+94.77%
1J Leistung:
-24.77%
1-Tages-Spanne:
$18.19
$19.97
1-Wochen-Bereich:
$14.89
$20.00
52-Wochen-Spanne:
$5.485
$31.13
Oruka Therapeutics Inc Stock (ORKA) Company Profile
Firmenname
Oruka Therapeutics Inc
Sektor
Branche
Telefon
650-606-7910
Adresse
855 OAK GROVE AVE., MENLO PARK
Vergleichen Sie ORKA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
18.62 | 930.43M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
404.21 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
599.94 | 59.59B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.65 | 59.77B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
767.33 | 45.14B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
335.16 | 37.42B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-22 | Eingeleitet | BTIG Research | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2024-10-11 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-17 | Eingeleitet | Leerink Partners | Outperform |
| 2024-09-16 | Eingeleitet | TD Cowen | Buy |
| 2024-09-13 | Eingeleitet | Jefferies | Buy |
| 2018-02-27 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2013-10-09 | Eingeleitet | Dawson James | Buy |
Alle ansehen
Oruka Therapeutics Inc Aktie (ORKA) Neueste Nachrichten
What drives Oruka Therapeutics Inc HQ1 stock priceDividend Stability Analysis & Budget Friendly Growth - earlytimes.in
Should you wait for a breakout in Oruka Therapeutics Inc.2025 Year in Review & Proven Capital Preservation Tips - newser.com
How Oruka Therapeutics Inc. (HQ1) stock reacts to monetary easing2025 Macro Impact & Verified Momentum Stock Ideas - newser.com
How Oruka Therapeutics Inc. stock performs in stagflationPortfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
How reliable is Oruka Therapeutics Inc. (HQ1) stock dividend growthInsider Buying & Comprehensive Market Scan Insights - newser.com
Is Oruka Therapeutics Inc. forming a bottoming base2025 Fundamental Recap & Short-Term High Return Strategies - newser.com
Oruka Therapeutics (NASDAQ:ORKA) Shares Gap UpWhat's Next? - MarketBeat
Can a trend reversal in Oruka Therapeutics Inc. lead to recoveryEarnings Trend Report & Verified Technical Trade Signals - newser.com
Custom strategy builders for tracking Oruka Therapeutics Inc.Forecast Cut & Capital Efficient Trade Techniques - newser.com
Oruka Therapeutics (NASDAQ:ORKA) Receives Buy Rating from BTIG Research - MarketBeat
Why retail traders accumulate Oruka Therapeutics Inc. (HQ1) stock2025 Pullback Review & Reliable Price Action Trade Plans - newser.com
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Oruka Therapeutics Inc Stock Analysis and ForecastContrarian Investment Ideas & Exceptional Return Opportunities - Early Times
Will Oruka Therapeutics Inc. stock deliver long term returns2025 Top Gainers & Expert Curated Trade Ideas - The British Mountaineering Council
BTIG Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Raises Target Price to $56 - 富途牛牛
Wall Street Zen Upgrades Oruka Therapeutics (NASDAQ:ORKA) to "Hold" - MarketBeat
Oruka Therapeutics (NASDAQ:ORKA) Trading Down 6.2%Should You Sell? - MarketBeat
Will Oruka Therapeutics Inc. continue its uptrendOptions Play & Entry Point Confirmation Alerts - newser.com
Is Oruka Therapeutics Inc. stock poised for growthMarket Activity Summary & Smart Allocation Stock Tips - newser.com
Quantitative breakdown of Oruka Therapeutics Inc. recent moveJuly 2025 Gainers & Growth Focused Entry Reports - newser.com
Oruka Therapeutics (NASDAQ:ORKA) Shares Gap Up Following Analyst Upgrade - MarketBeat
Oruka Therapeutics (NASDAQ:ORKA) Price Target Raised to $56.00 at BTIG Research - MarketBeat
Q3 EPS Forecast for Oruka Therapeutics Increased by Analyst - Defense World
Wedbush Forecasts Stronger Earnings for Oruka Therapeutics - MarketBeat
Oruka Therapeutics, Inc.(NasdaqGM: ORKA) added to S&P Global BMI Index - MarketScreener
Oruka Therapeutics, Inc.(NasdaqGM:ORKA) added to S&P Biotechnology Select Industry Index - MarketScreener
Visual analytics tools that track Oruka Therapeutics Inc. performanceJuly 2025 Setups & Safe Capital Growth Stock Tips - newser.com
Short Squeeze: Will Generation Income Properties Inc. Equity Warrant announce a stock splitWeekly Trade Recap & AI Optimized Trading Strategy Guides - khodrobank.com
Options Flow: Will Oruka Therapeutics Inc outperform tech stocksJuly 2025 Decliners & Expert Verified Movement Alerts - khodrobank.com
Will Oruka Therapeutics Inc. bounce back from current supportTrade Signal Summary & Free Accurate Trade Setup Notifications - newser.com
Analyzing Oruka Therapeutics Inc. with multi timeframe chartsTrade Entry Report & Consistent Profit Alerts - newser.com
Jobs Data: Can Oruka Therapeutics Inc deliver consistent EPS growthWeekly Market Summary & Daily Technical Stock Forecast Reports - خودرو بانک
Leerink Partners Maintains Oruka Therapeutics(ORKA.US) With Buy Rating - 富途牛牛
Is Oruka Therapeutics Inc. stock bottoming outPortfolio Profit Report & Stock Market Timing Techniques - newser.com
Finanzdaten der Oruka Therapeutics Inc-Aktie (ORKA)
Es liegen keine Finanzdaten für Oruka Therapeutics Inc (ORKA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.95%
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):